TABLE 1

Qualified Literature Data Available and Used for Subanalysis of Each of the 6 Identified Indications or Clinical Settings

ReferenceDiagnosisSensitivity and specificityUnknown primaryChange in managementCompared with OctreoScanCarcinoid tumors
Hofmann et al. (3)X
Buchman et al. (24)X
Gabriel et al. (8)XX
Frilling et al. (15)XXX
Ruf et al. (21)X
Versari et al. (9)X
Jindal et al. (16)XX
Kumar et al. (17)X
Poeppel et al. (19)X
Ruf et al. (10)X
Froeling et al. (20)X
Mayerhoefer et al. (11)X
Beiderwellen et al. (12)X
Schraml et al. (13)XX
Schreiter et al. (22)XX
Venkitaraman et al. (14)XX
Nakamoto et al. (18)XXX
Menda et al. (23)X